# Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects

> **NCT06348290** · PHASE1 · UNKNOWN · sponsor: **Jemincare** · enrollment: 72 (estimated)

## Conditions studied

- Solid Tumor, Adult

## Interventions

- **DRUG:** JMKX001899
- **DRUG:** Itraconazole
- **DRUG:** Midazolam
- **DRUG:** Rifampin
- **DRUG:** dextromethorphan
- **DRUG:** Rosuvastatin
- **DRUG:** digoxin

## Key facts

- **NCT ID:** NCT06348290
- **Lead sponsor:** Jemincare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-04-01
- **Primary completion:** 2024-05-31
- **Final completion:** 2024-09-15
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2024-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06348290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06348290, "Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06348290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*